These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 1572039

  • 21. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
    Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR.
    Circulation; 1992 Oct; 86(4):1241-8. PubMed ID: 1394930
    [Abstract] [Full Text] [Related]

  • 22. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M, Lensing AW, Büller HR, Prandoni P, Dooijewaard G, Cuppini S, ten Cate JW.
    Thromb Haemost; 1991 Oct 01; 66(4):426-9. PubMed ID: 1796391
    [Abstract] [Full Text] [Related]

  • 23. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
    Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ.
    J Am Coll Cardiol; 1998 Jul 01; 32(1):117-22. PubMed ID: 9669258
    [Abstract] [Full Text] [Related]

  • 24. Fibrinolytic effects of peroneal nerve stimulation in patients with lower limb vascular disease.
    Barnes R, Madden LA, Chetter IC.
    Blood Coagul Fibrinolysis; 2016 Apr 01; 27(3):275-80. PubMed ID: 26397885
    [Abstract] [Full Text] [Related]

  • 25. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 26. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G.
    Stroke; 2000 Jan 01; 31(1):26-32. PubMed ID: 10625711
    [Abstract] [Full Text] [Related]

  • 27. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement.
    Killewich LA, Macko RF, Cox K, Franklin DR, Benjamin ME, Lilly MP, Flinn WR.
    J Vasc Surg; 1997 Nov 01; 26(5):861-8. PubMed ID: 9372826
    [Abstract] [Full Text] [Related]

  • 28. Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?
    Gram J, Sidelmann J, Jespersen J.
    Thromb Haemost; 1995 Aug 01; 74(2):718-21. PubMed ID: 8585012
    [Abstract] [Full Text] [Related]

  • 29. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D.
    Thromb Haemost; 1987 Feb 03; 57(1):67-72. PubMed ID: 3109059
    [Abstract] [Full Text] [Related]

  • 30. External pneumatic compression and fibrinolysis in abdominal surgery.
    Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA.
    J Vasc Surg; 2000 Sep 03; 32(3):537-43. PubMed ID: 10957661
    [Abstract] [Full Text] [Related]

  • 31. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS, McLaren M, Hanslip J, Kerr M, Belch JJ.
    Ann Rheum Dis; 1993 Sep 03; 52(9):643-9. PubMed ID: 8239758
    [Abstract] [Full Text] [Related]

  • 32. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B.
    J Clin Pathol; 1994 Mar 03; 47(3):214-7. PubMed ID: 8163691
    [Abstract] [Full Text] [Related]

  • 33. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 03; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 34. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P, Koay ES, Tsakok M, Aw TC, Wong LY, Pradhan M.
    Thromb Haemost; 1988 Aug 30; 60(1):50-3. PubMed ID: 3142091
    [Abstract] [Full Text] [Related]

  • 35. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL, Fujii S, Sobel BE.
    Circulation; 1989 Jun 30; 79(6):1204-13. PubMed ID: 2498004
    [Abstract] [Full Text] [Related]

  • 36. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D.
    Thromb Haemost; 1991 Mar 04; 65(3):291-5. PubMed ID: 1904655
    [Abstract] [Full Text] [Related]

  • 37. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease.
    Smith FB, Lee AJ, Rumley A, Fowkes FG, Lowe GD.
    Atherosclerosis; 1995 May 04; 115(1):35-43. PubMed ID: 7669086
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke].
    Han XM, Chen ZQ, Mao HM.
    Zhonghua Nei Ke Za Zhi; 1990 Sep 04; 29(9):544-6, 575-6. PubMed ID: 2128260
    [Abstract] [Full Text] [Related]

  • 40. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 04; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.